The shortage of blood export from China has caused people to think deeply and worry
Description of the current situation:
The relatively low level of blood collection technology in China has become an unavoidable reality. There is still a long way to go between China's hematopoietic stem cell research level and the world's advanced level. This is not only directly related to the efficacy of Chinese patients, but also directly related to the competitiveness of Chinese people in the world.
The role of blood is becoming more and more widespread. In addition, there are many uses in medicine, scientific research, and other fields. Research on plasma preparation in China is still in its infancy. China has also made some progress in its economic and social development, but there is still a long way to go with the world's advanced level. Therefore, the competitiveness of Chinese plasma products in the world is not ideal.
Further expansion: It is undeniable that China's blood collection process is at a low level in the world. China's current scientific and technological strength and scientific and technological strength are still relatively backward compared with advanced countries, which seriously restricts the healthy development of China's whole blood products industry. Due to the frequent quality and safety problems of blood products produced in China, it is difficult for blood products produced in China to be comparable to high-grade blood products abroad.
Plasma is one of the main raw materials for the preparation of blood products. However, China's current blood supply is seriously insufficient, let alone imported, and even domestic needs cannot be guaranteed. This is a big problem for China because of its large population. The lack of clinical blood resources in China seriously restricts its efficacy and quality of life.
Blood products have a wide range of applications, in addition to various diseases, they also play an irreplaceable role in scientific research and medical treatment. However, there is still a big gap between research and innovation in the field of plasma preparation in China. Compared with the advanced level of foreign countries, China's research foundation in the field of hematology medicine and blood preparation is weak, and there is a lack of a product with independent intellectual property rights. This restricts the right of Chinese blood transfusion products to speak in the world market, and it cannot be "exported" at low prices.
Unpaid blood donation is a key step in blood collection and production of blood products. However, Chinese people still have little awareness of free donations, and the proportion of donations is not high. Many people also have a misconception about blood donation and are afraid that donating blood will have bad consequences for their body. Therefore, in China, the supply of plasma is relatively short, and there is a large gap between the demand and supply of plasma products. The sale of Chinese plasma products at low prices abroad not only reduces China's own supply, but also faces fierce competition abroad.
Abstract:A series of problems such as backward blood collection technology, small blood collection and supply, high blood collection cost and low product quality in China have attracted extensive attention and attention from all walks of life. China is a country with a large population, in order to enhance China's market competitiveness, we must strengthen the research on hematopoietic processing technology to improve China's hematopoietic function. If Chinese enterprises want to gain more profits, they must increase investment in scientific research, enhance their ability to innovate independently, gain more market share in the world, and make more contributions to the health of the people.
Blood is an essential part of the body, providing oxygen, nutrition, immunity and other functions for the body, which is essential for maintaining the normal functioning of the body. Blood products are a kind of food made from a special ingredient extracted from the human body, which has a wide range of applications and great medicinal value. Therefore, it is necessary to have a comprehensive understanding of the importance of blood collection and supply, enhance their understanding of blood collection and supply, and take the initiative to devote themselves to the development of blood collection and blood collection products.
From an individual point of view, if you want to make greater contributions to the motherland and society, you must ensure your physical health. Unpaid blood donation is a good thing that everyone can do, both for others and for their own health. On the other hand, the development of hematopoietic stem cell transplantation technology in China is also inseparable from the strong support of the state and the whole society. With our cooperation, the development of China's hematopoietic system will better serve people's health.